KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Accured Expenses (2017 - 2026)

Cardlytics filings provide 10 years of Change in Accured Expenses readings, the most recent being $586000.0 for Q1 2026.

  • Quarterly Change in Accured Expenses fell 69.08% to $586000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Mar 2026, down 170.47% year-over-year, with the annual reading at -$724000.0 for FY2025, 89.1% up from the prior year.
  • Change in Accured Expenses hit $586000.0 in Q1 2026 for Cardlytics, up from -$2.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.8 million in Q2 2022 and bottomed at -$11.6 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is -$1.4 million, with a median of -$44000.0 recorded in 2022.
  • The largest annual shift saw Change in Accured Expenses tumbled 1261.55% in 2022 before it soared 1627.27% in 2023.
  • Cardlytics' Change in Accured Expenses stood at -$3.7 million in 2022, then skyrocketed by 175.36% to $2.8 million in 2023, then plummeted by 223.73% to -$3.5 million in 2024, then grew by 27.98% to -$2.5 million in 2025, then skyrocketed by 123.57% to $586000.0 in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Change in Accured Expenses are $586000.0 (Q1 2026), -$2.5 million (Q4 2025), and $842000.0 (Q3 2025).